Literature DB >> 2964497

Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.

J Sprent1, M Schaefer, E K Gao, R Korngold.   

Abstract

Detailed information was sought on the capacity of purified Lyt-2+ cells to mediate lethal graft-versus-host disease (GVHD) directed to class I H-2 differences. When B6 Lyt-2+ cells were transferred to irradiated class I-different (B6 x bm 1)F1 mice, three different patterns of lethal GVHD were observed. First, rapid death from hematopoietic failure occurred when Lyt-2+ cells were transferred together with host-type marrow cells; this form of GVHD probably reflected direct destruction of stem cells by Lyt-2+ cytotoxic cells. Second, a pattern of late-onset, chronic GVHD resulting in death only after 4-6 wk occurred when Lyt-2+ cells were supplemented with donor marrow. This syndrome developed in the apparent absence of L3T4+ cells and was observed with either high or low doses of Lyt-2+ cells and with either light or heavy irradiation of the host. Third, an acute form of GVHD resulted when Lyt-2+ cells plus donor marrow cells were supplemented with exogenous help, i.e., by adding small doses of donor L3T4+ cells or injecting the hosts with rIL-2. Although L3T4+ cells potentiated GVHD when injected in small doses, supplementing Lyt-2+ cells with large doses of L3T4+ cells paradoxically led to marked protection; symptoms of GVHD were mild and no deaths occurred.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964497      PMCID: PMC2188839          DOI: 10.1084/jem.167.2.556

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  T cell subsets and graft-versus-host disease.

Authors:  R Korngold; J Sprent
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

Review 2.  Human marrow transplantation: an immunological perspective.

Authors:  P J Martin; J A Hansen; R Storb; E D Thomas
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

3.  Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.

Authors:  S Cobbold; G Martin; H Waldmann
Journal:  Transplantation       Date:  1986-09       Impact factor: 4.939

4.  T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2.

Authors:  M Malkovský; M K Brenner; R Hunt; S Rastan; C Doré; S Brown; M E North; G L Asherson; H G Prentice; P B Medawar
Journal:  Cell Immunol       Date:  1986-12       Impact factor: 4.868

5.  Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.

Authors:  D Maraninchi; E Gluckman; D Blaise; D Guyotat; B Rio; J L Pico; V Leblond; M Michallet; F Dreyfus; N Ifrah
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

6.  Graft rejection and graft-versus-host disease: mirror images.

Authors:  R P Gale; Y Reisner
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

7.  Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.

Authors:  T Mizuochi; T I Munitz; S A McCarthy; P M Andrysiak; J Kung; R E Gress; A Singer
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

8.  Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.

Authors:  J Goronzy; C M Weyand; C G Fathman
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

9.  Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.

Authors:  A S Rosenberg; T Mizuochi; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

10.  Studies on mouse leukaemia. The role of the thymus in leukaemogenesis by cell-free leukaemic filtrates.

Authors:  J F MILLER
Journal:  Br J Cancer       Date:  1960-03       Impact factor: 7.640

View more
  20 in total

Review 1.  Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses.

Authors:  A V Gorbachev; R L Fairchild
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.

Authors:  N Fukushi; H Arase; B Wang; K Ogasawara; T Gotohda; R A Good; K Onoé
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Authors:  T Teshima; G R Hill; L Pan; Y S Brinson; M R van den Brink; K R Cooke; J L Ferrara
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

4.  Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.

Authors:  J W Young; R M Steinman
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

5.  The cellular basis of the local graft-versus-host reaction in rat kidney.

Authors:  E M Bolton; J A Gracie; L A O'Reilly; J A Bradley
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.

Authors:  Y Ikarashi; K Kawai; H Watanabe; Y Matsumoto; S Omata; M Fujiwara
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

7.  Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.

Authors:  Brile Chung; Eric P Dudl; Dullei Min; Lora Barsky; Nancy Smiley; Kenneth I Weinberg
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

Review 8.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

9.  Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.

Authors:  S Shenoy; K Desch; B Duffy; P Thorson; T Mohanakumar
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

10.  In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Authors:  M Sykes; M L Romick; K A Hoyles; D H Sachs
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.